# Unicycive Therapeutics Announces Upcoming Presentation of New Data Reinforcing the Potential of Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia at the American Society of Nephrology Kidney Week 2025 Conference
Canonical URL: https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-announces-upcoming-presentation-of-new-data-reinforcing-the-potential-of-oxylanthanum-carbonate-for-the-treatment-of-hyperphosphatemia-at-the-american-society-of-nephrology-kidney-week-2025-conference
Ticker: UNCY
Company: Unicycive Therapeutics
Source: Unicycive Therapeutics
Published: 2025-10-30 11:05 EST
Original Source URL: https://ir.unicycive.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-06-30 11:05 EST — [Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)](https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-receives-complete-response-letter-from-fda-regarding-resu-2c152ab0) — Source: Unicycive Therapeutics
- 2026-05-12 11:05 EST — [Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update](https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-announces-first-quarter-2026-financial-results-and-provides-business-update) — Source: Unicycive Therapeutics
- 2026-04-09 11:05 EST — [Unicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference](https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-to-present-at-the-25th-annual-needham-virtual-healthcare-conference) — Source: Unicycive Therapeutics
- 2026-03-30 11:05 EST — [Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update](https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-announces-full-year-2025-financial-results-and-provides-business-update) — Source: Unicycive Therapeutics
- 2026-02-04 12:05 EST — [Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit](https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-to-participate-in-a-fireside-chat-at-guggenheim-s-emerging-outlook-biotech-summit) — Source: Unicycive Therapeutics
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)